Source: www.insidermedicine.ca
Author: staff

Click image to view movie

Scientists have identified an enzyme that may predict survival from head and neck cancer, according to a report presented at the annual meeting of the American Association for Cancer Research. Researchers analyzed tissue samples from over 100 squamous carcinoma patients, finding that those with low levels of the enzyme ERCC1 had increased chances of surviving the cancer following adjuvant therapy.

Print Friendly